A.-L. Taksin

High efficacy and safety profile of fractionated doses of Mylotarg as induction therapy in patients with relapsed acute myeloblastic leukemia: a prospective study of the alfa group

A.-L. Taksin, Ollivier Legrand, Emmanuel Raffoux et al. · Leukemia · 2006 · 282 citations

Hematological Malignancy, Oncology, Mixed-phenotype Acute Leukemia +10

Lenalidomide with or without erythropoietin in transfusion-dependent erythropoiesis-stimulating agent-refractory lower-risk MDS without 5q deletion

Andréa Toma, Olivier Kosmider, Sylvie Chevret et al. · Leukemia · 2015 · 120 citations · Full text

Hematological Malignancy, Transfusion Medicine, Hematology +4

Activity of fludarabine in previously treated Waldenström's macroglobulinemia: a report of 71 cases. Groupe Coopératif Macroglobulinémie.

V. Leblond, T Ben-Othman, Éric Deconinck et al. · Journal of Clinical Oncology · 1998 · 88 citations

Assessment of global longitudinal strain at low-dose anthracycline-based chemotherapy for the prediction of subsequent cardiotoxicity

C. Charbonnel, R. Convers-Domart, Sophie Rigaudeau et al. · Annales de Cardiologie et d Angéiologie · 2016 · 59 citations

Oncology, Subsequent Cardiotoxicity, Cardiovascular Toxicity +6

Daily practice management of myelodysplastic syndromes in France: data from 907 patients in a one-week cross-sectional study by the Groupe Francophone des Myelodysplasies

Charikleia Kelaïdi, Aspasia Stamatoullas, Odile Beyne‐Rauzy et al. · Haematologica · 2009 · 19 citations · Full text